Mankind Pharma Ltd
Mankind Pharma's GHG Emissions Data Preview
In 2024, Mankind Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Mankind Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Mankind Pharma's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Mankind Pharma amounted to 19,562 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Mankind Pharma decreased by 55.13%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Mankind Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Mankind Pharma's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Mankind Pharma were 5,831 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Mankind Pharma reduced its Scope 1 emissions over time?
Since 2022, Mankind Pharma's Scope 1 emissions have decreased by 62.98%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2023), Mankind Pharma's Scope 1 emissions decreased by 59.84%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Mankind Pharma's Scope 2 emissions?
In 2024, Mankind Pharma reported Scope 2 greenhouse gas (GHG) emissions of 13,731 tCOâ‚‚e without specifying the calculation method.
Has Mankind Pharma reduced its Scope 2 emissions over time?
Since 2022, Mankind Pharma's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 51.09%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2023), Mankind Pharma's Scope 2 emissions (Unspecified Calculation Method) fell by 52.78% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
What methodology does Mankind Pharma use for Scope 2 reporting?
In 2024, Mankind Pharma reported its Scope 2 emissions using an unspecified methodology.
Mankind Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)